0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Local Spinal Cord Injury Treatment Using a Dental Pulp Stem Cell Encapsulated H2S Releasing Multifunctional Injectable Hydrogel.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Spinal cord injury (SCI) commonly induces nerve damage and nerve cell degeneration. In this work, a novel dental pulp stem cells (DPSCs) encapsulated thermoresponsive injectable hydrogel with sustained hydrogen sulfide (H2S) delivery is demonstrated for SCI repair. For controlled and sustained H2S gas therapy, a clinically tested H2S donor (JK) loaded octysilane functionalized mesoporous silica nanoparticles (OMSNs) are incorporated into the thermosensitive hydrogel made from Pluronic F127 (PF-127). The JK-loaded functionalized MSNs (OMSF@JK) promote preferential M2-like polarization of macrophages and neuronal differentiation of DPSCs in vitro. OMSF@JK incorporated PF-127 injectable hydrogel (PF-OMSF@JK) has a soft consistency similar to that of the human spinal cord and thus, shows a high cytocompatibility with DPSCs. The cross-sectional micromorphology of the hydrogel shows a continuous porous structure. Last, the PF-OMSF@JK composite hydrogel considerably improves the in vivo SCI regeneration in Sprague-Dawley rats through a reduction in inflammation and neuronal differentiation of the incorporated stem cells as confirmed using western blotting and immunohistochemistry. The highly encouraging in vivo results prove that this novel design on hydrogel is a promising therapy for SCI regeneration with the potential for clinical translation.

          Related collections

          Author and article information

          Journal
          Adv Healthc Mater
          Advanced healthcare materials
          Wiley
          2192-2659
          2192-2640
          Apr 2024
          : 13
          : 9
          Affiliations
          [1 ] Center of Regenerative Medicine, Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
          [2 ] School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
          [3 ] Laboratory for Regenerative Medicine, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei, 430064, China.
          [4 ] Oral Maxillofacial Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
          [5 ] College of Life and Environmental Science, Wenzhou University, Wenzhou, Zhejiang, 325035, China.
          [6 ] Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.
          [7 ] Department of Orthopaedics, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China.
          [8 ] Wenzhou Institute, University of China Academy of Science, Wenzhou, Zhejiang, 325024, China.
          [9 ] School of Materials Science and Engineering, University of New South Wales, Sydney, New South Wales, 2052, Australia.
          [10 ] Australian Center for NanoMedicine, University of New South Wales, Sydney, New South Wales, 2052, Australia.
          [11 ] School of Pharmacy, University of Queensland, Brisbane, Queensland, 4102, Australia.
          Article
          10.1002/adhm.202302286
          38056013
          0e254892-3af2-40b4-80b1-e97727c1a66c
          History

          thermoresponsive hydrogel,controlled drug delivery,mesoporous silica nanoparticles,spinal cord injuries, stem cell therapy

          Comments

          Comment on this article